David A. Siegel Morphic Holding, Inc. Transaction History

Two Sigma Advisers, LP

$42.5 Billion
Q1 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 385,100 shares of MORF stock, worth $12.9 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

385,100

Previous 555,100 30.63%

Holding current value

$12.9 Million

Previous $16 Million 15.45%

% of portfolio

0.03%

Previous 0.04%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$26.64 - $40.31 $4.53 Million - $6.85 Million	-170,000 Reduced 30.63%	385,100 $13.6 Million
Q4 2023 Feb 14, 2024	BUY	$19.95 - $31.0 $7.66 Million - $11.9 Million	383,900 Added 224.24%	555,100 $16 Million
Q3 2023 Nov 14, 2023	BUY	$21.33 - $59.42 $3.56 Million - $9.91 Million	166,700 Added 3704.44%	171,200 $3.92 Million
Q2 2023 Aug 14, 2023	BUY	$34.33 - $62.11 $154,485 - $279,495	4,500 New	4,500 $257,000
Q4 2022 Feb 14, 2023	SELL	$24.14 - $30.37 $140,012 - $176,146	-5,800 Reduced 25.55%	16,900 $452,000

Q3 2022 Nov 14, 2022	SELL	$22.23 - $33.37 $509,067 - $764,172	-22,900 Reduced 50.22%	22,700 $642,000
Q2 2022 Aug 15, 2022	BUY	$19.74 - $43.01 $667,212 - $1.45 Million	33,800 Added 286.44%	45,600 $990,000
Q1 2022 May 16, 2022	SELL	$36.25 - $52.02 $246,500 - $353,736	-6,800 Reduced 36.56%	11,800 $474,000
Q4 2021 Feb 14, 2022	BUY	$43.27 - $65.72 $38,943 - $59,148	900 Added 5.08%	18,600 $881,000
Q3 2021 Nov 15, 2021	SELL	$53.61 - $67.5 $150,108 - $189,000	-2,800 Reduced 13.66%	17,700 $1 Million
Q2 2021 Aug 16, 2021	SELL	$45.13 - $64.99 $63,182 - $90,986	-1,400 Reduced 6.39%	20,500 $1.18 Million
Q1 2021 May 17, 2021	BUY	$29.77 - $84.85 $651,963 - $1.86 Million	21,900 New	21,900 $1.39 Million

Others Institutions Holding MORF

# of Institutions

142

Shares Held

37.9M

Call Options Held

13.5K

Put Options Held

190K

View Full List

About Morphic Holding, Inc.

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $1.29B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

More about MORF

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account